Trial Profile
A retrospective study evaluating the switching dynamics between etanercept biosimilar and etanercept original.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
- Focus Therapeutic Use
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 22 May 2017 New trial record